-transparent.png){kind=logo}
A double-blind study of twenty-eight patients with severe oral lichen planus treated with etretinate (75 mg daily) or a placebo for 2 months, showed that the oral retinoid had a marked beneficial effect. Nine non-responders who had received only placebo then entered an open cross-over study and they responded well to etretinate. Etretinate thus provided effective symptomatic relief for severe oral lichen planus, but side-effects were common, and six patients stopped treatment because of them.
Related Publications
K Hersle, and
H Mobacken, and
K Sloberg, and
H Thilander
September 1984,
Oral surgery, oral medicine, and oral pathology,
K Hersle, and
H Mobacken, and
K Sloberg, and
H Thilander
October 1979,
Zeitschrift fur Hautkrankheiten,
K Hersle, and
H Mobacken, and
K Sloberg, and
H Thilander
April 1986,
Geburtshilfe und Frauenheilkunde,
K Hersle, and
H Mobacken, and
K Sloberg, and
H Thilander
January 1983,
Annales de dermatologie et de venereologie,
K Hersle, and
H Mobacken, and
K Sloberg, and
H Thilander
January 1983,
Acta dermato-venereologica,
K Hersle, and
H Mobacken, and
K Sloberg, and
H Thilander
January 1984,
Revista medica de Chile,
K Hersle, and
H Mobacken, and
K Sloberg, and
H Thilander
January 1986,
Vestnik dermatologii i venerologii,
K Hersle, and
H Mobacken, and
K Sloberg, and
H Thilander
March 1988,
International journal of dermatology,
K Hersle, and
H Mobacken, and
K Sloberg, and
H Thilander
February 2013,
The Australasian journal of dermatology,
K Hersle, and
H Mobacken, and
K Sloberg, and
H Thilander
January 1983,
Medicina cutanea ibero-latino-americana,
